🔎 Trials Near Me

Beranda › Kanker Ovarium › Ohio › Dayton

Uji klinis Kanker Ovarium di Dayton, OH

9 studi untuk Kanker Ovarium mencari peserta di lokasi sekitar Dayton (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Menerima pesertaFase 2
  • Miami Valley Hospital, Dayton
  • Premier Blood and Cancer Center, Dayton
  • Miami Valley Hospital North, Dayton
  • dan 5 lainnya
Semua usia · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05564377

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Menerima pesertaFase 3
  • Miami Valley Hospital South, Centerville · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07213804

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Menerima pesertaFase 3
  • Miami Valley Hospital South, Dayton
Usia 18 ke atas · Wanita · Diperbarui 15 Sep 2026 · NCT07214779

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Menerima peserta
  • Miami Valley Hospital, Dayton
  • Miami Valley Hospital North, Dayton
  • Miami Valley Hospital South, Centerville · 9 mi jauhnya
  • dan 2 lainnya
Usia 35 hingga 50 · Wanita · Diperbarui 7 Agu 2026 · NCT04251052

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Menerima pesertaFase 2
  • 304, Centerville · 9 mi jauhnya
Usia 18 ke atas · Wanita · Diperbarui 16 Jul 2026 · NCT06906341

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Menerima pesertaFase 3
  • Miami Valley Hospital South, Centerville · 9 mi jauhnya
Usia 18 ke atas · Wanita · Diperbarui 2 Jul 2026 · NCT06819007

Uji klinis Kanker Ovarium di kota lain

Studi lain di Dayton

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.